Group structure
3 companies in 2 countries
United Kingdom1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
1–25 of 35
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| MST Continus 10 mg | Morphine | Saudi Arabia | Authorised | |
| MST Continus 30 mg | Morphine | Saudi Arabia | Authorised | |
| MST Continus 60 mg | Morphine | Saudi Arabia | Authorised | |
| OXYNORM 10MG CAPSULE | Oxycodone | Saudi Arabia | Authorised | |
| OXYNORM 20MG/2ML AMPOULE | Oxycodone | Saudi Arabia | Authorised | |
| OXYNORM 20MG CAPSULE | Oxycodone | Saudi Arabia | Authorised | |
| OXYNORM 5MG CAPSULE | Oxycodone | Saudi Arabia | Authorised | |
| TARGINACT 10MG/5MG PR TABLET | Oxycodone, Naloxone | Saudi Arabia | Authorised | |
| TARGINACT 20MG/10MG PR TABLET | Oxycodone, Naloxone | Saudi Arabia | Authorised | |
| TARGINACT 40MG/20MG PR TABLET | Oxycodone, Naloxone | Saudi Arabia | Authorised | |
| BAR-BUPRENORPHINE20 mcg / hour · Patch | Buprenorphine | Canada | Cancelled | |
| BAR-BUPRENORPHINE5 mcg / hour · Patch | Buprenorphine | Canada | Cancelled | |
| BAR-BUPRENORPHINE10 mcg / hour · Patch | Buprenorphine | Canada | Cancelled | |
| BAR-BUPRENORPHINE15 mcg / hour · Patch | Buprenorphine | Canada | Cancelled | |
| BAR-HYDROMORPHONE CR4.5 mg · Capsule (Extended-Release) | Hydromorphone | Canada | Cancelled | |
| BAR-HYDROMORPHONE CR18 mg · Capsule (Extended-Release) | Hydromorphone | Canada | Cancelled | |
| BAR-HYDROMORPHONE CR24 mg · Capsule (Extended-Release) | Hydromorphone | Canada | Cancelled | |
| BAR-HYDROMORPHONE CR9 mg · Capsule (Extended-Release) | Hydromorphone | Canada | Cancelled | |
| BAR-HYDROMORPHONE CR3 mg · Capsule (Extended-Release) | Hydromorphone | Canada | Cancelled | |
| BAR-HYDROMORPHONE CR6 mg · Capsule (Extended-Release) | Hydromorphone | Canada | Cancelled | |
| BAR-HYDROMORPHONE CR12 mg · Capsule (Extended-Release) | Hydromorphone | Canada | Cancelled | |
| BAR-HYDROMORPHONE CR30 mg · Capsule (Extended-Release) | Hydromorphone | Canada | Cancelled | |
| BAR-METHYLPHENIDATE HCL CR20 mg · Capsule (Extended-Release) | Methylphenidate | Canada | Cancelled | |
| BAR-METHYLPHENIDATE HCL CR50 mg · Capsule (Extended-Release) | Methylphenidate | Canada | Cancelled | |
| BAR-METHYLPHENIDATE HCL CR60 mg · Capsule (Extended-Release) | Methylphenidate | Canada | Cancelled |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 25 | 0 | 25 | CompaniesAll medicines |
| Saudi Arabia | 10 | 10 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- AnalgesicsNervous system · ATC N02A
- PsychoanalepticsNervous system · ATC N06B
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- bard pharmaceuticals 1990
- bard urological div
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Pharmaceutical group
- Companies
- 3
- Medicines
- 35
- Countries
- 2